We are live on ! Find out more
JSAM

J. Safra Asset Management Portfolio holdings

AUM $2.17B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+12.24%
1 Year Est. Return
+29.66%
3 Year Est. Return
+84.26%
5 Year Est. Return
+107.54%
10 Year Est. Return
AUM
$1.44B
AUM Growth
+$206M
Cap. Flow
+$66.8M
Cap. Flow %
4.65%
Top 10 Hldgs %
69.3%
Holding
403
New
58
Increased
145
Reduced
95
Closed
36

Sector Composition

Rank Sector Weight
1 Technology 2.8%
2 Communication Services 1.33%
3 Financials 1.09%
4 Consumer Discretionary 0.77%
5 Healthcare 0.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVMD icon
351
Revolution Medicines
RVMD
$43.8B
$1.88K ﹤0.01%
51
VKTX icon
352
Viking Therapeutics
VKTX
$3.98B
$1.85K ﹤0.01%
+70
New +$1.84K
NRIX icon
353
Nurix Therapeutics
NRIX
$2.69B
$1.8K ﹤0.01%
158
+61
+63% +$659
SMMT icon
354
Summit Therapeutics
SMMT
$11.9B
$1.77K ﹤0.01%
+83
New +$1.89K
SYK icon
355
Stryker
SYK
$134B
$1.58K ﹤0.01%
4
AGL icon
356
Agilon Health
AGL
$1.56B
$1.56K ﹤0.01%
+27
New +$2.17K
RNAM
357
DELISTED
Avidity Biosciences
RNAM
$1.45K ﹤0.01%
51
GILD icon
358
Gilead Sciences
GILD
$167B
$1.11K ﹤0.01%
10
+1
+11% +$106
GKOS icon
359
Glaukos
GKOS
$10.7B
$930 ﹤0.01%
9
+1
+13% +$94
NUVL
360
DELISTED
Nuvalent
NUVL
$687 ﹤0.01%
9
+2
+29% +$146
INSP icon
361
Inspire Medical Systems
INSP
$1.75B
$649 ﹤0.01%
5
SLNO
362
DELISTED
Soleno Therapeutics
SLNO
$586 ﹤0.01%
7
FTRE icon
363
Fortrea Holdings
FTRE
$1.81B
$514 ﹤0.01%
104
IRON icon
364
Disc Medicine
IRON
$3.12B
$318 ﹤0.01%
6
CGON icon
365
CG Oncology
CGON
$6.71B
$286 ﹤0.01%
+11
New +$265
ORKA
366
Oruka Therapeutics
ORKA
$6.19B
$269 ﹤0.01%
+24
New +$250
OXY.WS icon
367
Occidental Petroleum Corp Warrants
OXY.WS
$35.2B
$83 ﹤0.01%
4
ACHC icon
368
Acadia Healthcare
ACHC
$2.91B
-348
Closed -$10.6K
ATI icon
369
ATI
ATI
$31.2B
-253
Closed -$13.2K
BRKR icon
370
Bruker
BRKR
$8.62B
-11
Closed -$459
DE icon
371
Deere & Co
DE
$167B
-170
Closed -$79.8K
DELL icon
372
Dell
DELL
$285B
-3,741
Closed -$341K
EXC icon
373
Exelon
EXC
$46.2B
-1
Closed -$39
FISV
374
Fiserv Inc
FISV
$28B
-1,326
Closed -$293K
FND icon
375
Floor & Decor
FND
$6.42B
-2,144
Closed -$173K

Similar funds

J. Safra Asset Management's Q2 2025 Portfolio in Review

As of Q2 2025, J. Safra Asset Management held 403 positions worth $1.44B, up 17% from $1.23B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

J. Safra Asset Management deployed $66.8M of net new capital in Q2 2025, opening 58 new positions and adding to 145 existing holdings. Its largest new stake was JPMorgan Ultra-Short Municipal Income ETF: 88,398 shares worth $4.5M.

By sector, the portfolio is most concentrated in Technology at 2.8% of assets, up from 2.2% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $1.07M trimmed.

  • J. Safra Asset Management's largest Q2 2025 buy was JPMorgan Ultra-Short Municipal Income ETF: 88,398 shares worth $4.5M.
  • J. Safra Asset Management added most to Listed Funds Trust Roundhill Magnificent Seven ETF in Q2 2025, an estimated $31.4M increase.
  • J. Safra Asset Management's biggest Q2 2025 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $1.07M.
  • J. Safra Asset Management fully exited State Street SPDR S&P Biotech ETF in Q2 2025, selling an estimated $25.2M.
  • J. Safra Asset Management's ten largest holdings make up 69% of its $1.44B portfolio in Q2 2025.
  • J. Safra Asset Management opened 58 new positions and closed 36 in Q2 2025.
  • J. Safra Asset Management's portfolio value rose 17% quarter-over-quarter to $1.44B.

Based on J. Safra Asset Management's 13F filing for Q2 2025, filed 28 Jul 2025.